Move is an IT infrastructure consulting company and system integrator covering the areas of Network and Security, Virtualization, Database and OS platforms, and high-end server/storage. Move delivers: High expertise advisor and consultancy services Design and implementation of complex projects Diversified service and support services Project Management IT-solutions

Entro is an energy- and environmental consultancy firm with two clients – our customers and the environment. We save our customers time and money, and we help the environment by reducing energy consumption and carbon footprints. Entro has about 60 employees in Oslo, Trondheim, and Bergen. We had a turnover of NOK 63 million in 2016 and saved our customers NOK 400 million. Entro has a unique interdisciplinary expertise with a good mix of practical and academic skills. Among our staff we have more trade certificates in electrical and construction, more than 60% of the employees are civil engineers and engineers and we have several employees with training in economics and management. We have expertise in electrical, plumbing, building, environment, and IT.

Yetz is a new distribution platform for product lines such as insurance, electricity, telecom, and finance. At launch, we will offer both insurance and power. We utilize strong incentives towards our customers and partners to share the concept, by giving them an affiliate commission. Monthly payment is based on the turnover of customers they have referred. Two fully owned sister companies Yetz Strøm og Yetz Forsikring.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Halify AS operates on markets within the field of urban spatial area management, with a specific focus on Intelligent Transport Systems (ITS) and urban mobility. We have supplied solutions for Horizon2020-funded projects (VICINITY, CrossMove, BIG IoT), and received support from the Research Council of Norway on projects like Komét and Sparkling, and cooperated with the NCE environment in Horten and Oslo. We are active within several consortiums and part of the Smart Cities Norway network, the ENIT network, and ITS Arena. We have developed solutions for calculating and visualizing the environmental impact made by the transport industry on Norwegian municipalities, and take pride in visualizing difficult concepts and results in a way that is easy to convey.

A bio-and medtech Company developing and selling proprietary solutions for using oxygen in various applications. Currently focussing on beverages (water, sports- and isotonic drinks), wound healing, cosmetics and fish farming. Licensing platform technology for applying oxygent to other products. Oxy Solutions is a privately held Norwegian based biotech company that has developed and patented an innovative technology for highly oxygenating liquid. Oxy Solutions'​ core business and strategy is to develop, document, IP protect, and commercialize the technology primarily within wound healing. The company has an in-house R&D facility in Norway. The company has funding from the Norwegian Research Council. Oxy Solutions is in possession of patented technology that makes it possible to greatly increase the dissolved level of oxygen in water. Tests have indicated stable levels in excess of 70 mg/l, or approximately 10 times higher than previously thought possible.

Om prosjektet – fra slam til brenselDet skal bygges og utvikles et mobilt prosessanlegg som gjør slam/avfall fra havbruksnæringen om til brennbart materiale.Brenselet vil det ha et stort potensiale i sementproduksjon eller fjernvarmeanlegg. Vi vil også selge tørket slam tilbake til havbruksnæringen/oppdrettsanlegg som energi. Prosjektet er i oppstartsfasen og skal ha fokus på teknologiutvikling, samt etablering av løsninger for slamhåndtering, mat- og bioavfall.Våre kunder er klekkerier, smoltanlegg, testanlegg i sjø (lukkede merder), sementproduksjon, fjernvarmeanlegg. Vi har og det samme segmentet i utlandsmarkedet.

Total Kropp- trening og behandling er et tverrfaglig behandlingssenter med naprapater, fysioterapeut, lege og personlige trenere. Vi har i tillegg et fullt utstyrt treningssenter der man kan trene individuelt, få rehabilitering, trene med personlig trener eller i grupper på 3-6 personer. På senteret har vi et velfungerende tverrfaglig samarbeid der man kan få felleskonsultasjon med f.eks naprapat og lege.

Building a "børs"  for the worlds non for profit organisation in Oslo. Oslo Philanthropic Exchange is a non-profit foundation. Our mission is to bring the best practice from the global capital markets to raise philanthropic funding more efficiently. Our goal is to contribute to higher impact of philanthropic capital. The OPX Solution addresses the inefficient funding of the non-profit sector and the lack of standardised, transparent and comparable data. By applying best practice from the capital markets for listing of non-profit organisations and reporting requirements as well as leveraging existing infrastructures, we standardise and digitalise to increase efficiency, transparency, accountability and accessibility. The OPX Solution represent the complete value chain of finding, filtering, funding and following the world’s non-profit organisations.

Aqua Alarm is developing a Biological Water Alarm System (BiWAS). There are three things that make BiWAS stand out from all other comparable products: 1) It provides real-time monitoring 2) It monitors a broad spectrum of toxicants, carcinogens and pathogens 3) It does this in a very cost-effective way We have among other things been through the av Horizon 2020 phase 1 project and are presently performing two projects to prove the technology in real environments. We are interested in industrial and development partners.

Avidly is a fully integrated MarTech service provider covering every aspect of the customer experience. We´re 3 x Global HubSpot Partner of the Year and as an Elite HubSpot Solutions Partner, we share the tool with our customers to consistently help them grow their businesses. We are a one-stop-shop for digital marketing and sales. We help companies grow by providing them technical and creative solutions that makes a difference. Together with our clients we always strive to find new ways to growth.

Salire AS is a Norwegian tech-startup that develops applications that help small and medium sizes businesses grow. Our product AIFlow is an innovative CRM solution tailored around hundreds of Norwegian businesses. We like to call it a boosted CRM because it offers an all in one experience with a simple interface, eliminating the need for many applications to run your business daily.

We help rental services get ready for the future The development is clear – We need to make better use of our resources. We need a more circular economy where products are reused by more people and have a longer lifetime. In this picture, renting and subscription of products and services plays an important role. Sharefox has developed a technology platform that enables new models for both startups and established businesses. We are a passionate and highly skilled team of about 12 persons in Oslo, and 10 developers working remotely. In March 2022 we secured 23 million NOK in funding, and will use this money to scale the company further, including going internationally. You can currently find us at Vollebekk Fabrikker in Oslo, but will move to an other place in Oslo in the autumn of 2022.

DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug development more effective. We use state-of-the-art methods to improve patients’ quality of life and help clinicians make more informed decisions. Our technology is based on pioneering research on utilizing artificial intelligence to increase the prognostic value from routine clinical pathology cancer tissue samples. The extensive research conducted at top universities (University in Oslo, Oxford University and University College of London) has been published in leading and high impact scientific journals such as The Lancet and Nature Reviews Cancer. These new methods have resulted in fully automated histotyping that provide objective and precise prognostic information that correlate and out-perform existing markers. This novel histotyping can guide selection of therapy to avoid over- and undertreatment. It can also make cancer drug development more effective by ensuring more precise diagnosis and prognosis, which is the fundament for precision medicine. Artificial intelligence is set for a breakthrough in medicine and several megatrends are pushing for new solutions in cancer diagnostics. Digital pathology and new AI algorithms will play a significant role in the future of medicine and hold multiple commercial opportunities. DoMore Diagnostics is at the forefront of the field and will bring these next generation products to the clinic.

The WAYD application helps sport-teams gain funds and engage with their supporters through premium albums. By creating premium albums you are giving supporters the opportunity to subscribe to an album, support your team, and contribute to the album. Supporters can pick between several levels of memberships they will pay as a monthly or one-time subscription price for joining your album. You can set these tiers while creating the album.